
Please try another search
Vacasa, Inc. (VCSA) +25%; reported Q2 EPS of $0.02, $0.20 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $310 million versus the consensus estimate of $285.46 million.
Veru, Inc. (NASDAQ:VERU) +20%; announced financial results for its fiscal 2022 third quarter ended June 30, 2022, and sabizabulin for COVID progress towards regulatory decisions in key territories.
Matterport, Inc. (MTTR) +20%; reported Q2 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $28.5 million versus the consensus estimate of $29.6 million. Matterport, Inc. sees Q3 2022 EPS of ($0.15)-($0.13), versus the consensus of ($0.13). Matterport, Inc. sees Q3 2022 revenue of $35-37 million, versus the consensus of $32.95 million.
Walt Disney (NYSE:DIS) +10%; after the company reported stronger-than-expected Disney+ subscriber numbers for Q3.
Dutch Bros Inc. (BROS) +8%; reported Q2 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $186.4 million versus the consensus estimate of $182.24 million.
InVitae (NVTA) -24%; surged 275% yesterday.
Sonos (NASDAQ:SONO) -17%; reported Q3 EPS of $0.19, $0.13 better than the analyst estimate of $0.06. Revenue for the quarter came in at $371.8 million versus the consensus estimate of $424.03 million. Sonos sees FY2022 revenue of $1.73-1.76 billion, versus the consensus of $1.96 billion.
Six Flags Entertainment (NYSE:SIX) -15%; reported Q2 EPS of $0.53, $0.51 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $435 million versus the consensus estimate of $527.45 million.
Bumble (NASDAQ:BMBL) -13%;reported Q2 EPS of ($0.03), $0.02 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $220 million versus the consensus estimate of $219.55 million.
AppLovin (APP) -10%; reported Q2 EPS of ($0.06), $0.21 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $776 million versus the consensus estimate of $839.67 million. AppLovin sees FY2022 revenue of $2.84-3.14 billion, versus the consensus of $3.29 billion.
GlaxoSmithKline (NYSE:GSK) -9% on worries related to Zantac litigation.
Sanofi (NASDAQ:SNY) -9% on worries related to Zantac litigation.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.